Works matching IS 00316970 AND DT 2024 AND VI 80 AND IP 9
Results: 16
Synergizing pharmacometrics and pharmacovigilance for medication error management: the case of secukinumab.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1339, doi. 10.1007/s00228-024-03705-6
- By:
- Publication type:
- Article
Characteristics and preventability of medication-related admissions for acute kidney injury and dehydration in elderly patients.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1355, doi. 10.1007/s00228-024-03704-7
- By:
- Publication type:
- Article
Development and validation of individualized tacrolimus dosing software for Chinese pediatric liver transplantation patients: a population pharmacokinetic approach.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1409, doi. 10.1007/s00228-024-03717-2
- By:
- Publication type:
- Article
Population pharmacokinetics of free and liposome-encapsulated mitoxantrone in patients with relapsed/refractory lymphoma or small cell lung cancer.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1399, doi. 10.1007/s00228-024-03711-8
- By:
- Publication type:
- Article
How can polymyxin B be dosed based on current pharmacokinetic knowledge?
- Published in:
- 2024
- By:
- Publication type:
- Letter
Assessment of a systematic approach for implementing novel medications in clinical practice: an observational study with dapagliflozin.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1363, doi. 10.1007/s00228-024-03707-4
- By:
- Publication type:
- Article
Quantitative evaluation of the efficacy and safety profiles of two types of targeted inhibitors combined with endocrine therapy in ER+/HER2− metastatic breast cancer.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1387, doi. 10.1007/s00228-024-03715-4
- By:
- Publication type:
- Article
Treatment-related adverse events in patients with advanced breast cancer receiving adjuvant AKT inhibitors: a meta-analysis of randomized controlled trials.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1373, doi. 10.1007/s00228-024-03713-6
- By:
- Publication type:
- Article
Population pharmacokinetic, pharmacodynamic and efficacy modeling of SB12 (proposed eculizumab biosimilar) and reference eculizumab.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1325, doi. 10.1007/s00228-024-03703-8
- By:
- Publication type:
- Article
The safety and efficacy of bevacizumab in treatment of recurrent low-grade glioma: a systematic review and meta-analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1259, doi. 10.1007/s00228-024-03695-5
- By:
- Publication type:
- Article
Population pharmacokinetics and dosage optimization of linezolid in Chinese older patients.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1295, doi. 10.1007/s00228-024-03702-9
- By:
- Publication type:
- Article
Reliability and validity of the Swedish indicator 'Drugs that should be avoided in older people'—an appraisal of a set of potentially inappropriate medications.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1285, doi. 10.1007/s00228-024-03700-x
- By:
- Publication type:
- Article
Trends in statin use for the primary prevention of atherosclerotic cardiovascular disease among US adults by demographic characteristics, 1999–2020.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1305, doi. 10.1007/s00228-024-03699-1
- By:
- Publication type:
- Article
Assessment of body mass-related covariates for rifampicin pharmacokinetics in healthy Caucasian volunteers.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1271, doi. 10.1007/s00228-024-03697-3
- By:
- Publication type:
- Article
Apixaban plasma concentrations in patients with obesity.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1343, doi. 10.1007/s00228-024-03696-4
- By:
- Publication type:
- Article
Clinical and biochemical characteristics, and outcome in 33 patients with ceftriaxone-induced liver injury.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1317, doi. 10.1007/s00228-024-03701-w
- By:
- Publication type:
- Article